Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | F-1/A | tm2016252-15_f1a.htm | F-1/A | 5154648 |
| 2 | EXHIBIT 3.1 | tm2016252d8_ex3-1.htm | EX-3.1 | 284255 |
| 3 | EXHIBIT 4.1 | tm2016252d17_ex4-1.htm | EX-4.1 | 168587 |
| 4 | EXHIBIT 10.38 | tm2016252d17_ex10-38.htm | EX-10.38 | 76897 |
| 5 | EXHIBIT 10.39 | tm2016252d17_ex10-39.htm | EX-10.39 | 35408 |
| 6 | EXHIBIT 10.40 | tm2016252d17_ex10-40.htm | EX-10.40 | 31049 |
| 7 | EXHIBIT 23.1 | tm2016252d15_ex23-1.htm | EX-23.1 | 3557 |
| 8 | EXHIBIT 99.8 | tm2016252d17_ex99-8.htm | EX-99.8 | 3035 |
| 9 | EXHIBIT 99.9 | tm2016252d17_ex99-9.htm | EX-99.9 | 2641 |
| 10 | EXHIBIT 99.10 | tm2016252d17_ex99-10.htm | EX-99.10 | 2675 |
| 11 | EXHIBIT 99.11 | tm2016252d17_ex99-11.htm | EX-99.11 | 3530 |
| 12 | EXHIBIT 99.12 | tm2016252d17_ex99-12.htm | EX-99.12 | 3429 |
| 13 | GRAPHIC | lg_curevacfpo-4clr.jpg | GRAPHIC | 40504 |
| 14 | GRAPHIC | tm2016252d6-fc_product4clr.jpg | GRAPHIC | 163875 |
| 15 | GRAPHIC | tm2016252d6_riderbofa42820.jpg | GRAPHIC | 387706 |
| 16 | GRAPHIC | tm2016252d6_fc-transfpo4c.jpg | GRAPHIC | 512034 |
| 17 | GRAPHIC | tm2016252d6_fc-bodyfpo4c.jpg | GRAPHIC | 394911 |
| 18 | GRAPHIC | tm2016252d6_fc-rnaooptfpo.jpg | GRAPHIC | 188317 |
| 19 | GRAPHIC | tm2016252d6_fc-exploongfpo.jpg | GRAPHIC | 223595 |
| 20 | GRAPHIC | tm2016252d6_lc-halffpo4c.jpg | GRAPHIC | 496744 |
| 21 | GRAPHIC | tm2016252d6_lc-half2fpo4c.jpg | GRAPHIC | 148797 |
| 22 | GRAPHIC | tm2016252d6_lc-prodesfpo4c.jpg | GRAPHIC | 103023 |
| 23 | GRAPHIC | tm2016252d6_fc-prodesfpo4c.jpg | GRAPHIC | 188729 |
| 24 | GRAPHIC | tm2016252d6_lc-modimfpo4c.jpg | GRAPHIC | 125271 |
| 25 | GRAPHIC | tm2016252d6_fc-sequence4c.jpg | GRAPHIC | 167979 |
| 26 | GRAPHIC | tm2016252d6-mrna.jpg | GRAPHIC | 161398 |
| 27 | GRAPHIC | tm2016252d6_bc-activfpo4c.jpg | GRAPHIC | 229630 |
| 28 | GRAPHIC | tm2016252d6-successive.jpg | GRAPHIC | 274950 |
| 29 | GRAPHIC | tm2016252d6_bc-optutrfpo4c.jpg | GRAPHIC | 117502 |
| 30 | GRAPHIC | tm2016252d6_bc-optorffpo4c.jpg | GRAPHIC | 160928 |
| 31 | GRAPHIC | tm2016252d6_bc-opt3endfpo4c.jpg | GRAPHIC | 137075 |
| 32 | GRAPHIC | tm2016252d6-diverse.jpg | GRAPHIC | 218699 |
| 33 | GRAPHIC | tm2016252d6_sc-vaclpnfpo.jpg | GRAPHIC | 303470 |
| 34 | GRAPHIC | tm2016252d6_sc-cvcmfpo4c.jpg | GRAPHIC | 179561 |
| 35 | GRAPHIC | tm2016252d6-cvcm.jpg | GRAPHIC | 135676 |
| 36 | GRAPHIC | tm2016252d6-production.jpg | GRAPHIC | 127751 |
| 37 | GRAPHIC | tm2016252d6_ph-buildfpo4c.jpg | GRAPHIC | 2379805 |
| 38 | GRAPHIC | tm2016252d6_ph-curevac4clr.jpg | GRAPHIC | 1604041 |
| 39 | GRAPHIC | tm2016252d6-ph_tumor4clr.jpg | GRAPHIC | 616245 |
| 40 | GRAPHIC | tm2016252d6-tbl_prelim4clr.jpg | GRAPHIC | 596008 |
| 41 | GRAPHIC | tm2016252d6-fc_cohorts4clr.jpg | GRAPHIC | 684971 |
| 42 | GRAPHIC | tm2016252d6-tbl_prefer4clr.jpg | GRAPHIC | 571212 |
| 43 | GRAPHIC | tm2016252d6-bc_prelim4clr.jpg | GRAPHIC | 2141159 |
| 44 | GRAPHIC | tm2016252d6_ph-melanfpo4c.jpg | GRAPHIC | 250665 |
| 45 | GRAPHIC | tm2016252d6-ph_lesions4clr.jpg | GRAPHIC | 279473 |
| 46 | GRAPHIC | tm2016252d6_ph-metafpo4c.jpg | GRAPHIC | 199853 |
| 47 | GRAPHIC | tm2016252d6_ph-pretrefpo4c.jpg | GRAPHIC | 130174 |
| 48 | GRAPHIC | tm2016252d6_lc-survfpo4c.jpg | GRAPHIC | 197463 |
| 49 | GRAPHIC | tm2016252d6_lc-tumorfpo4c.jpg | GRAPHIC | 152552 |
| 50 | GRAPHIC | tm2016252d6_lc-tumor2fpo4c.jpg | GRAPHIC | 180661 |
| 51 | GRAPHIC | tm2016252d6_lc-abscofpo4c.jpg | GRAPHIC | 179721 |
| 52 | GRAPHIC | tm2016252d6_fc-dosek.jpg | GRAPHIC | 168274 |
| 53 | GRAPHIC | tm2016252-6_riderg42820.jpg | GRAPHIC | 135900 |
| 54 | GRAPHIC | tm2016252d6-lc_cv72024c.jpg | GRAPHIC | 483505 |
| 55 | GRAPHIC | tm2016252d6-bc_sars4clr.jpg | GRAPHIC | 201098 |
| 56 | GRAPHIC | tm2016252d6-bc_induc4clr.jpg | GRAPHIC | 528620 |
| 57 | GRAPHIC | tm2016252d6-bc_kinet4clr.jpg | GRAPHIC | 993673 |
| 58 | GRAPHIC | tm2016252-6_riderf42820.jpg | GRAPHIC | 40922 |
| 59 | GRAPHIC | tm2016252d6_lc-influenfpo4c.jpg | GRAPHIC | 384598 |
| 60 | GRAPHIC | tm2016252d6_bc-servntfpoo4c.jpg | GRAPHIC | 317224 |
| 61 | GRAPHIC | tm2016252d6_bc-lungfpoo4c.jpg | GRAPHIC | 250006 |
| 62 | GRAPHIC | tm2016252d6_fc-liverfpo4c.jpg | GRAPHIC | 124269 |
| 63 | GRAPHIC | tm2016252d6_sc-25hcfpo4c.jpg | GRAPHIC | 178879 |
| 64 | GRAPHIC | tm2016252d6_fc-therafpo4c.jpg | GRAPHIC | 726221 |
| 65 | GRAPHIC | tm2016252d6_lc-aminofpo4c.jpg | GRAPHIC | 171145 |
| 66 | GRAPHIC | tm2016252d6_ph-ccl4fpo4c.jpg | GRAPHIC | 551026 |
| 67 | GRAPHIC | tm2016252d6_lc-dfpo4c.jpg | GRAPHIC | 74949 |
| 68 | GRAPHIC | tm2016252d6_lc-gfpo4c.jpg | GRAPHIC | 83627 |
| 69 | GRAPHIC | tm2016252d6_lc-rituxfpo4c.jpg | GRAPHIC | 115145 |
| 70 | GRAPHIC | tm2016252d6_fc-retinafpo4c.jpg | GRAPHIC | 277281 |
| 71 | GRAPHIC | tm2016252d6_sc-areabuff.jpg | GRAPHIC | 636142 |
| 72 | GRAPHIC | tm2016252d6_bc-levelsfpo4c.jpg | GRAPHIC | 185529 |
| 73 | GRAPHIC | lg_curevac-fpo.jpg | GRAPHIC | 79401 |
| 74 | GRAPHIC | tm2016252d17_10xxxximg01.jpg | GRAPHIC | 3807 |
| Complete submission text file | 0001104659-20-091817.txt | 35746293 |
EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-240076 | Film No.: 201084135
SIC: 2834 Pharmaceutical Preparations
